Literature DB >> 8390395

Diagnosis and follow-up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography.

K Ikeda1, S Saitoh, I Koida, A Tsubota, Y Arase, K Chayama, H Kumada.   

Abstract

To clarify the angiographic features of small hepatocellular carcinoma, we performed digital subtraction angiography in 91 patients with hepatocellular carcinomas of 2 cm or less. Repeated digital subtraction angiography studies were performed in 25 patients whose first angiograms showed no tumor staining. Digital subtraction angiography showed hypervascular tumor staining in only 51 patients (56.0%). We found that the smaller a tumor nodule was, the lower the detection rate of tumor stain on digital subtraction angiography. The detection rate of hypervascularity was closely correlated with the grading of histological differentiation of the tumors: well-differentiated hepatocellular carcinomas more often showed negative tumor staining. Repeated digital subtraction angiography studies showed alteration of tumor staining from isovascular to hypervascular in 6 of 6 patients with tumors that became larger than 2 cm and in 12 of 19 patients with tumors that remained 2 cm or smaller. Conversion of vascularity is commonly found in the early stage of small hepatocellular carcinoma, and the process is usually slow, taking approximately 1 yr.

Entities:  

Mesh:

Year:  1993        PMID: 8390395

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Thalidomide-based multidisciplinary treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis.

Authors:  Yang-Yuan Chen; Hsu-Heng Yen; Kun-Ching Chou; Shun-Sheng Wu
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

2.  Use of FDP and F1P aldolase to detect tumorous and nontumorous tissue damage by ethanol injection of hepatocellular carcinoma.

Authors:  K N Khan; K Nakata; K Nakao; Y Kato; K Eguchi
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 3.  Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue®.

Authors:  Veronica Salvatore; Alice Gianstefani; Giulia Negrini; Giulia Allegretti; Marzia Galassi; Fabio Piscaglia
Journal:  Liver Cancer       Date:  2015-12-18       Impact factor: 11.740

4.  Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound.

Authors:  H-X Xu; M-D Lu; L-N Liu; Y-F Zhang; L-H Guo; J-M Xu; C Liu
Journal:  Br J Radiol       Date:  2012-05-02       Impact factor: 3.039

5.  Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population.

Authors:  Balkrishan Sharma; Radhika Srinivasan; Yogesh Kumar Chawla; Shweta Kapil; Nitin Saini; Bhupesh Singla; Anuradha Chakraborthy; Naveen Kalra; Ajay Duseja; Radha Krishan Dhiman
Journal:  Hepatol Int       Date:  2010-07-13       Impact factor: 6.047

6.  Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States.

Authors:  Brian I Carr; Futoshi Kanke; Margaret Wise; Shinji Satomura
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

7.  Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.

Authors:  Chen-Shiou Wu; Teng-Yu Lee; Ruey-Hwang Chou; Chia-Jui Yen; Wei-Chien Huang; Chung-Yi Wu; Yung-Luen Yu
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.